TIOTROPIUM inhalation (Spiriva Respimat®▼) for asthma in children and young people - Pan Mersey APC Skip to main content Help with accessibility Skip to main navigation

TIOTROPIUM inhalation (Spiriva Respimat®▼) for asthma in children and young people

Last Updated: 24 May 2018

Body System: Respiratory system

Grey

The Pan Mersey Area Prescribing Committee does not currently recommend the prescribing of TIOTROPIUM inhalation (Spiriva Respimat®▼) for asthma in children and young people < 18 years of age.